Last Modified: February 1, 2004
Conference Dates: March 21-23, 2004
Conference Location: Copper Mountain Colorado
Sponsoring Group: University of S. Florida and Moffitt Cancer Center
Conference Web Page URL: www.moffitt.usf.edu/promotions/modalities
Topics Covered: Molecular targeted therapies, clinical drug resistance, immunotherapy, functional genomics, stem cells and cancer
Conference Objectives: Identify new molecular targets for cancer therapy and prevention, recognize status of the role of gene expression, SNP's and protenomics in prognosis and treatment, evaluate the current and latest advances and developments in tumor vaccine strategies, identify emergfing theories concerning stem cell origins for cancer.
Who Should Attend: Medical radiation and surgical oncologists, cancer reserachers, pharmacists, PA's, nurses
Registration Information: www.moffitt.usf.edu/promotions/modalities or call (813) 632-1741
Conference Fees: Physicians and pharmacists $500 or $600 after 2-27-04
Continuing Education: Yes
Sep 22, 2010 - No new evidence has emerged warranting a change in the U.S. Preventive Services Task Force's 2004 conclusion that screening asymptomatic men for testicular cancer is unlikely to offer benefits over clinical detection, according to a literature review in the Sept. 21 issue of the Annals of Internal Medicine.
Sep 22, 2010